(Q36035933)

PubMed publication ID

27247353

11 August 2017

title

Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

0 references

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

author name string

Eric Polley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

Mark Kunkel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

David Evans

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

Thomas Silvers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

Rene Delosh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

Julie Laudeman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

Chad Ogle

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

Russell Reinhart

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

Michael Selby

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

John Connelly

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

Erik Harris

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

Nicole Fer

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

Gurmeet Kaur

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

Anne Monks

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

Shakun Malik

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

Joel Morris

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

Beverly A Teicher

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

31 May 2016

1 reference

PubMed publication ID

27247353

Journal of the National Cancer Institute

11 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

Small cell lung cancer: will recent progress lead to improved outcomes?

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Novel strategies for the treatment of small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

A comprehensive transcriptional portrait of human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Small cell lung cancer: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

The molecular pathogenesis of small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

A small-cell lung cancer genome with complex signatures of tobacco exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Comprehensive genomic profiles of small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

A novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Mitosis, microtubule dynamics and the evolution of kinesins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

A phase I trial of MK-0731, a kinesin spindle protein (KSP) inhibitor, in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

A framework for identification of actionable cancer genome dependencies in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Increased insulin-like growth factor 1 receptor protein expression and gene copy number in small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Targeting small cell lung cancer harboring PIK3CA mutation with a selective oral PI3K inhibitor PF-4989216.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

MicroRNA expression and clinical outcome of small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

microRNA regulation of cell viability and drug sensitivity in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

BCL-2 family antagonists for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Different forms of cell death induced by putative BCL2 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Targeting BCL2-Proteins for the Treatment of Solid Tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

AKT/mTOR pathway activation and BCL-2 family proteins modulate the sensitivity of human small cell lung cancer cells to RAD001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Phase II study of everolimus (RAD001) in previously treated small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Hitting the brakes: targeting microtubule motors in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Global microRNA analysis of the NCI-60 cancer cell panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

Pharmaco-miR: linking microRNAs and drug effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW122

MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer.

21 January 2018

1 reference

12 December 2020

The emerging role of microRNAs in drug responses

1 reference

12 December 2020

Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?

1 reference

12 December 2020

NCI-Navy Medical Oncology Branch cell line data base

1 reference

12 December 2020

Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJW122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6279282&resulttype=core&format=json

13 May 2020

PubMed publication ID

27247353

1 reference